Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/13/1998 | EP0840622A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
05/13/1998 | EP0840621A1 Hormone patch |
05/13/1998 | EP0840611A1 Oral acyclovir delivery |
05/13/1998 | EP0840603A1 Pharmaceutical composition of l-dopa ethyl ester |
05/13/1998 | EP0840600A1 Transdermal patch containing aspirin |
05/13/1998 | EP0840599A1 Pharmaceutical compositions of conjugated estrogens and methods for their use |
05/13/1998 | EP0840598A1 Alkalinizing potassium salt controlled release preparations |
05/13/1998 | EP0840597A1 Hydrogel patch |
05/13/1998 | EP0840595A1 Sunscreen compositions |
05/13/1998 | EP0840570A2 Apparatus and method for making gas-filled vesicles of optimal size |
05/13/1998 | EP0591492B1 A pharmaceutical composition containing a defined lipid system |
05/13/1998 | EP0506860B1 Nicotine packaging materials |
05/13/1998 | CN2281178Y Analgesic paste |
05/13/1998 | CN1181705A Gel form of a vaccine |
05/13/1998 | CN1181703A Controlled release of miotic and mydriatic drugs in the anterior chamber |
05/13/1998 | CN1181269A Pain relieving antiphlogistine and its prepn. method |
05/13/1998 | CN1181268A Medicinal paste for removing scar |
05/13/1998 | CN1181266A Medicine for eliminating urinary organ stones |
05/13/1998 | CN1181261A Application of herbs in preparing sterilizing and anti-inflammatory medicines |
05/13/1998 | CN1181254A Rheumatism paste and its preparing method |
05/13/1998 | CN1181252A External-use medicine for skin and its prepn. method |
05/13/1998 | CN1181249A Paste for treating child diarrhoea |
05/13/1998 | CN1181243A Cauma spray agent and its prodn. method |
05/13/1998 | CN1181239A Method for preparing film forming sterilizing agent |
05/13/1998 | CN1181237A 固体药物制剂 The solid pharmaceutical preparation |
05/12/1998 | US5750678 Water-soluble dextran fatty acid esters and their use as solubilizers |
05/12/1998 | US5750651 Cartilage and bone-inducing proteins |
05/12/1998 | US5750585 Super absorbent hydrogel foams |
05/12/1998 | US5750579 Solution of disinfectant, alcohol, thickener |
05/12/1998 | US5750571 Methods and therapeutic compositions for treating cystic fibrosis |
05/12/1998 | US5750563 Preparation for epidermis |
05/12/1998 | US5750561 Compositions containing taxane derivatives |
05/12/1998 | US5750559 Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs |
05/12/1998 | US5750557 Method and pharmaceutical formulation for treating benign prostatic hyperplasia |
05/12/1998 | US5750514 Method for controlling ectoparasites |
05/12/1998 | US5750512 For treatment of parkinson's and alzheimer's disease or mental depression |
05/12/1998 | US5750321 Process for buffering concentrated aqueous slurries |
05/12/1998 | US5750148 Cellulosic enteric base |
05/12/1998 | US5750147 Fungicides for oral administration |
05/12/1998 | US5750146 Translucent collagen formulations with a cytotoxic drug |
05/12/1998 | US5750145 Stable gelatin coated aspirin tablets |
05/12/1998 | US5750143 Controlled release device |
05/12/1998 | US5750142 Lyophilized; cryoprotectants; emulsifiers; oil in water emulsion |
05/12/1998 | US5750140 Transdermal delivery of tiagabine |
05/12/1998 | US5750139 Contained in inner space between impermeable top layer and microporous membrane welded togather |
05/12/1998 | US5750138 Drug delivery, hydrolyzable ester |
05/12/1998 | US5750137 Drug delivery, permeability, glycerides and lactates |
05/12/1998 | US5750136 Mucosal surfaces; drug delivery; sustained release |
05/12/1998 | US5750134 Bioadhesive composition and patch |
05/12/1998 | US5750131 Ifosfamide lyophilizate preparations |
05/12/1998 | US5750124 W/O/W emulsions |
05/12/1998 | US5750103 Method for transplanting cells into the brain and therapeutic uses therefor |
05/12/1998 | US5750100 Drug delivery of an active peptide or protein by injection or implantation by incorporating in a matrix of a polyglycerol diester of a saturated fatty acid; nondenaturing; antiallergens |
05/12/1998 | CA2033277C Controlled release pharmaceutical preparation and method for producing the same |
05/12/1998 | CA2012469C Polyurethanes |
05/07/1998 | WO1998019351A2 Nanostructured ion conducting solid electrolytes |
05/07/1998 | WO1998019311A1 Electrically conductive adhesive hydrogels |
05/07/1998 | WO1998018829A1 Adhesives with low level of residual monomers and process for manufacturing same |
05/07/1998 | WO1998018810A1 Immunostimulatory nucleic acid molecules |
05/07/1998 | WO1998018610A1 Embedding and encapsulation of controlled release particles |
05/07/1998 | WO1998018500A2 Improvements in or relating to diagnostic/therapeutic agents |
05/07/1998 | WO1998018492A1 Method of inhibiting drug precipitation |
05/07/1998 | WO1998018484A1 Therapeutic agent and method for feline aids virus infections and feline atopic dermatitis |
05/07/1998 | WO1998018479A1 Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract |
05/07/1998 | WO1998018472A1 Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators |
05/07/1998 | WO1998018468A1 Synergistic composition comprising rapamycin and calcitriol |
05/07/1998 | WO1998018463A1 Anthelmintic formulation |
05/07/1998 | WO1998018455A1 Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules |
05/07/1998 | WO1998018454A1 Aqueous enteric coating compositions |
05/07/1998 | WO1998018453A1 Oral vaccines for young animals with an enteric coating |
05/07/1998 | WO1998018452A1 Soluble form osmotic dose delivery system |
05/07/1998 | WO1998018451A2 Substituted amylose as a matrix for sustained drug release |
05/07/1998 | WO1998018450A1 Ionophore-mediated liposome loading of weakly basic drug |
05/07/1998 | WO1998018449A1 Methods of preventing breast cancer |
05/07/1998 | WO1998018448A1 Use of polyethylene glycol-9 nonylphenyl ether |
05/07/1998 | WO1998018441A1 Cleansing products |
05/07/1998 | WO1998018417A1 Fatty acid esters of lactic acid salts as permeation enhancers |
05/07/1998 | WO1998018416A1 Fatty acid esters of glycolic acid and its salts as permeation enhancers |
05/07/1998 | WO1998018346A2 Neutral-tasting microcapsules, method for their manufacturing and their use |
05/07/1998 | WO1998018339A1 Chewing gum composition and process for the production thereof |
05/07/1998 | WO1998018338A1 Fat-coated encapsulation compositions and method for preparing the same |
05/07/1998 | WO1998018325A1 Prophylaxis of breast cancer |
05/07/1998 | WO1998009985A3 Anti-inflammatory peptides and uses thereof |
05/07/1998 | WO1998009633A3 Pharmaceutical compositions |
05/07/1998 | WO1998008536A3 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity |
05/07/1998 | WO1998007415A3 Methods for prevention of cellular proliferation and restenosis |
05/07/1998 | WO1998005360A3 Use of (meth)acrylic acid copolymers to increase the permeability of mucous membranes |
05/07/1998 | WO1998005300A3 Delivery system for pharmaceutical agents encapsulated with oils |
05/07/1998 | WO1998004242A3 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
05/07/1998 | WO1998003159A3 Lipid-binding proteins and their therapeutic and diagnostic use |
05/07/1998 | DE19645712A1 Herstellung von trockenen Lactulose-Arzneiformen Production of dry lactulose dosage forms |
05/07/1998 | DE19645319A1 Foaming composition, useful as skin care medium e.g. as shaving foam |
05/07/1998 | CA2270373A1 Synergistic composition comprising rapamycin and calcitriol |
05/07/1998 | CA2270345A1 Immunostimulatory nucleic acid molecules |
05/07/1998 | CA2270254A1 Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators |
05/07/1998 | CA2269985A1 Improvements in or relating to diagnostic/therapeutic agents |
05/07/1998 | CA2263334A1 Fatty acid esters of lactic acid salts as permeation enhancers |
05/07/1998 | CA2263300A1 Fatty acid esters of glycolic acid and its salts as permeation enhancers |
05/06/1998 | EP0839572A2 Method of granulating powder and apparatus for it |
05/06/1998 | EP0839533A1 Methods of preventing breast cancer by the administration of Raloxifene |